Date: 12 Oct 2012
Telomeres and Tissue Engineering: The Potential Roles of TERT in VEGF-mediated Angiogenesis
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Telomeres are protective structures located at the end of eukaryotic chromosomes which are shortened after each cell division, leading to senescence. Telomerase activity prevents telomere shortening by reverse transcription catalyzed by the subunit called TERT (telomerase reverse transcriptase). TERT expression has shown interesting cellular properties, which may be appealing for tissue engineering, such as the enhancement of cell proliferation and differentiation abilities in vitro. Despite some evidence for playing these roles in VEGF (vascular endothelial growth factor)-mediated angiogenesis, it is still unclear whether TERT can contribute to this essential event to generate functional organs. This review suggests a hypothesis that TERT and VEGF potentially regulates the transcriptional expression of each other, which would give new perspectives in the roles of telomerase in regulating several cellular processes, and also contributing for a better comprehension of the molecular mechanisms underlying VEGF signaling (both paracrine and autocrine). In general, based on the literature revised, it is possible to conclude that TERT is a potential VEGF enhancer; however, it is necessary to elaborate methodological approaches to explore this potential and to assess the potential benefits on tissue engineering approaches.
An erratum to this article can be found at http://dx.doi.org/10.1007/s12015-013-9444-5.
Pampalona, J., Soler, D., Genesca, A., & Tusell, L. (2010). Whole chromosome loss is promoted by telomere dysfunction in primary cells. Genes, Chromosomes and Cancer, 49, 368–378.
Hornsby, P. J. (2010). Cellular aging and cancer. Critical Reviews Oncology/Hematology, 79, 189–195.CrossRef
Shukla, S., Acharya, S., Rajput, D., Vagha, S., & Grover, S. (2010). Telomere–the twilight to immortality. Journal of the Association of Physicians of India, 58, 553–560.PubMed
Nedel, F., Andre, D. A., de Oliveira, I. O., Cordeiro, M. M., Casagrande, L., Tarquinio, S. B., et al. (2009). Stem cells: therapeutic potential in dentistry. Journal of Contemporary Dental Practice, 10, 90–96.PubMed
Giordano, R. J., Cardo-Vila, M., Salameh, A., Anobom, C. D., Zeitlin, B. D., Hawke, D. H., et al. (2010). From combinatorial peptide selection to drug prototype (I): targeting the vascular endothelial growth factor receptor pathway. Proceedings of the National Academy of Sciences of the United States of America, 107, 5112–5117.PubMedCrossRef
Sirma, H., Kumar, M., Meena, J. K., Witt, B., Weise, J. M., Lechel, A., et al. (2011). The promoter of human telomerase reverse transcriptase is activated during liver regeneration and hepatocyte proliferation. Gastroenterology, 141(326–37), 337.
Liang, X. J., Chen, X. J., Yang, D. H., Huang, S. M., Sun, G. D., & Chen, Y. P. (2011). Differentiation of human umbilical cord mesenchymal stem cells into hepatocyte-like cells by hTERT gene transfection in vitro. Cell Biology International, 36, 215–221.CrossRef
He, X. Y., Zheng, Y. M., Lan, J., Wu, Y. H., Yan, J., He, X. N., et al. (2011). Recombinant adenovirus-mediated human telomerase reverse transcriptase gene can stimulate cell proliferation and maintain primitive characteristics in bovine mammary gland epithelial cells. Development, Growth & Differentiation, 53, 312–322.CrossRef
Tang, J., Wang, Z., Li, X., Li, J., & Shi, H. (2008). Human telomerase reverse transcriptase expression correlates with vascular endothelial growth factor-promoted tumor cell proliferation in prostate cancer. Artificial Cells, Blood Substitutes and Biotechnology, 36, 83–93.CrossRef
Bermudez, Y., Yang, H., Saunders, B. O., Cheng, J. Q., Nicosia, S. V., & Kruk, P. A. (2007). VEGF- and LPA-induced telomerase in human ovarian cancer cells is Sp1-dependent. Gynecologic Oncolcology, 106, 526–537.CrossRef
Shkreli, M., Sarin, K. Y., Pech, M. F., Papeta, N., Chang, W., Brockman, S. A., et al. (2012). Reversible cell-cycle entry in adult kidney podocytes through regulated control of telomerase and Wnt signaling. Nature Medicine, 18, 111–119.CrossRef
Strong, M. A., Vidal-Cardenas, S. L., Karim, B., Yu, H., Guo, N., & Greider, C. W. (2011). Phenotypes in mTERT/ and mTERT/ mice are due to short telomeres, not telomere-independent functions of telomerase reverse transcriptase. Molecular and Cell Biology, 31, 2369–2379.CrossRef
Donnini, S., Solito, R., Cetti, E., Corti, F., Giachetti, A., Carra, S., et al. (2010). Abeta peptides accelerate the senescence of endothelial cells in vitro and in vivo, impairing angiogenesis. The Journal of the Federation of American Societies for Experimental Biology, 24, 2385–2395.
Minamino, T., & Komuro, I. (2008). Vascular aging: insights from studies on cellular senescence, stem cell aging, and progeroid syndromes. Nature Reviews Cardiology, 5, 637–648.
de Jesus, B.B., Schneeberger, K., Vera, E., Tejera, A., Harley, C.B., & Blasco, M.A. (2011). The telomerase activator TA-65 elongates short telomeres and increases health span of adult/old mice without increasing cancer incidence. Aging Cell
Xie, M., Chen, Q., He, S., Li, B., & Hu, C. (2011). Silencing of the human TERT gene by RNAi inhibits A549 lung adenocarcinoma cell growth in vitro and in vivo. Oncology Reports, 26, 1019–1027.PubMed
Kotsakis, A., Vetsika, E. K., Christou, S., Hatzidaki, D., Vardakis, N., Aggouraki, D., et al. (2012). Clinical outcome of patients with various advanced cancer types vaccinated with an optimized cryptic human telomerase reverse transcriptase (TERT) peptide: results of an expanded phase II study. Annals of Oncology, 23, 442–449.PubMedCrossRef
- Telomeres and Tissue Engineering: The Potential Roles of TERT in VEGF-mediated Angiogenesis
Stem Cell Reviews and Reports
Volume 8, Issue 4 , pp 1275-1281
- Cover Date
- Print ISSN
- Online ISSN
- Humana Press Inc
- Additional Links
- Endothelial cells
- Industry Sectors
- Author Affiliations
- 1. Biotechnology Unit, Technology Development Center, Federal University of Pelotas, Rio Grande do Sul, Brazil
- 2. Post-Graduate Program in Dentistry and Biotechnology Unit, Technology Development Center, Federal University of Pelotas, Rio Grande do Sul, Brazil
- 3. Post-Graduate Program in Dentistry, Federal University of Pelotas, Rio Grande do Sul, Brazil
- 4. Department of Cardiology, Restorative Sciences, and Endodontics, University of Michigan, Ann Arbor, MI, USA
- 5. Post-Graduate Program in Dentistry, Federal University of Pelotas, Rio Grande do Sul, Brazil